Status:

COMPLETED

Comparison of Biphozyl® and Phoxilium® as a Replacement Fluid During CVVH for AKI in Adults and Their Effects on pH-, Bicarbonate-levels and Respiratory Situation

Lead Sponsor:

Medical University Innsbruck

Conditions:

Critically Ill

Acute Kidney Injury

Eligibility:

All Genders

18-120 years

Phase:

PHASE2

Brief Summary

The primary objectives of the BiPhox-Trial are to demonstrate, that the use of Biphozyl® as a replacement fluid in adult critically ill acute kidney injury (AKI) patients, results in a lower rate of p...

Detailed Description

After being fully eligible by meeting all inclusion and none of the exclusion criteria, participants will be randomly assigned to one of two groups, either the Phoxilium® - Group or Biphozyl® - Group....

Eligibility Criteria

Inclusion

  • Age ≥ 18 years
  • Admission to Intensive Care Unit
  • Indication for CVVH as determined by the attending physician
  • Planned CVVH treatment time ≥ 48 hours
  • Written informed consent or deferred consent or legally acceptable representative consent

Exclusion

  • Lack of commitment to provide CVVH as part of limitation of ongoing life support
  • Presence of a drug overdose that may result in acid-base-disorders and/or a shift of electrolytes
  • Receipt of CVVH within the previous 72 hours
  • Dialysis dependent end-stage renal disease
  • Pregnancy, must be ruled out by anamnesis and/or blood or urine pregnancy test
  • Combination of severely impaired liver function and shock with muscle hypoperfusion
  • Co-enrollment in another trial, which could have a plausible interaction with the acid-base-status and/or any electrolytes
  • Subjects, who are legally exempted from participation in clinical trials (e.g. persons held in an institution by legal or official order)

Key Trial Info

Start Date :

August 1 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 11 2024

Estimated Enrollment :

88 Patients enrolled

Trial Details

Trial ID

NCT04071171

Start Date

August 1 2020

End Date

March 11 2024

Last Update

March 13 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Division of Intensive Care and Emergency Medicine, Department of Internal Medicine, Medical University Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria

Innsbruck, Tyrol, Austria, 6020